Pfizer’s CEO Albert Bourla has revamped sales tactics, leading to a 31% rise in U.S. sales of Nurtec migraine medication, reports The Wall Street Journal.
President Xi plans to meet with Qualcomm and Saudi Aramco CEOs following this year’s China Development Forum, according to ...
After learning doctors weren’t prescrbing its migraine drug Nurtec because they assumed insurance coverage would be a hassle, the company ...
The drugmaker has revamped how it packages, promotes and sells certain medicines in an effort to overcome a postpandemic ...